The challenges in treating AIDS, malaria, tuberculosis, chagas and others can be reduced to certain limit by use of correct formulation type i.e., nanosuspensions. These diseases demand attention of pharma R & D’s to invest resources for developing effective drug delivery systems. Many published reports confirmed that the nanocrystal would serve as an ideal industrially feasible option and can save several active compounds coming from high throughput screening. Intracellular drug targeting at therapeutic level is very essential for these pathogens which form latent sanctuaries at cellular and subcellular level.
https://doi.org/10.1007/s40005-013-0051-x
